論文業績

   

2021 年


26. An Aicardi-Goutières Syndrome-Causative Point Mutation in Adar1 Gene Invokes
      Multiorgan Inflammation and Late-Onset Encephalopathy in Mice.

       Inoue M, Nakahama T, Yamasaki R, Shibuya T, Kim JI, Todo H, Xing Y, Kato Y, Morii E,
       Kawahara Y.
         J Immunol. 2021 Nov 12:ji2100526. doi: 10.4049/jimmunol.2100526. Online ahead of print.

25. Mitochondria govern histone acetylation in colorectal cancer.
      Ohshima K, Oi R, Nojima S, Morii E.
         J Pathol. 2021 Oct 26. doi: 10.1002/path.5818. Online ahead of print.

24. Mitochondrial matrix protein C14orf159 attenuates colorectal cancer metastasis by
      suppressing Wnt/β-catenin signalling.

       Ohshima K, Oi R, Okuzaki D, Motooka D, Shinohara M, Nojima S, Morii E.
         Br J Cancer. 2021 Oct 23. doi: 10.1038/s41416-021-01582-9. Online ahead of print.

23. Nicotinamide N-methyltransferase is related to MELF pattern invasion in
      endometrioid carcinoma.

       Tahara S, Nojima S, Ohshima K, Hori Y, Sato K, Kurashige M, Matsui T, Okuzaki D, Morii E.              Cancer Med. 2021 Oct 16. doi: 10.1002/cam4.4359. Online ahead of print.

22. The Japanese Society of Pathology Practical Guidelines on the handling of
      pathological tissue samples for cancer genomic medicine.

        Hatanaka Y, Kuwata T, Morii E, Kanai Y, Ichikawa H, Kubo T, Hatanaka KC, Sakai K,
        Nishio K, Fujii S, Okamoto W, Yoshino T, Ochiai A, Oda Y.
          Pathol Int. 2021 Oct 6. doi: 10.1111/pin.13170. Online ahead of print.

21. APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS
     and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense
     mutation.

      Kobayashi T, Makino T, Yamashita K, Saito T, Tanaka K, Takahashi T, Kurokawa Y,
      Yamasaki M, Nakajima K, Morii E, Eguchi H, Doki Y.
         Br J Cancer. 2021 Oct 1. doi: 10.1038/s41416-021-01561-0. Online ahead of print.

20. Intraocular Endoscopy Resolved Tube Occlusion of an Ahmed Glaucoma Valve.
       Kawashima R, Baba K, Matsushita K, Soma T, Kurashige M, Umeda D, Nakamura M, Morii E,
       Nishida K.
         Case Rep Ophthalmol. 2021 Aug 24;12(2):706-711.

19. Adult-Onset Biotinidase Deficiency Induces Acutely Progressing Leukoencephalopathy.
      Beck G, Hirozawa D, Honma K, Baba K, Sumi H, Morii E, Murayama S, Mochizuki H.
        Neurol Clin Pract. 2021 Jun;11(3):e383-e386.

18. Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the
      efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal
      adenocarcinoma.

       Amano T, Iijima H, Shinzaki S, Tashiro T, Iwatani S, Tani M, Otake Y, Yoshihara T,
       Sugimoto A, Egawa S, Yamaguchi S, Kinoshita K, Araki M, Hirao M, Sakakibara Y, Hiyama S,
       Ogawa H, Nagaike K, Murata J, Komori M, Okuda Y, Kizu T, Tsujii Y, Hayashi Y, Inoue T,
       Takahashi H, Mizushima T, Morii E, Takehara T.
          BMC Cancer. 2021 Aug 31;21(1):978.

17. Polycythemia Vera Associated with Pulmonary Hypertension and Diffuse Large B-Cell
      Lymphoma: A Case Report.

        Kameda S, Sera F, Sato K, Kurashige M, Higo S, Ohtani T, Tsuboi A, Hikoso S, Morii E,
        Yamaguchi O, Yamauchi-Takihara K, Sakata Y.
          Am J Case Rep. 2021 Aug 26;22:e932956.

16. Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes
      in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer.

        Noma T, Makino T, Ohshima K, Sugimura K, Miyata H, Honma K, Yamashita K, Saito T,
        Tanaka K, Yamamoto K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Morii E,
        Eguchi H, Doki Y.
          Ann Surg. 2021 Jul 29. doi: 10.1097/SLA.0000000000005104. Online ahead of print.

15. Durable response of chemotherapy for cancer of unknown primary with unfavorable
      subset developed in retroperitoneal space.

       Matsukawa A, Kato T, Kondo F, Kawasaki K, Kawashima A, Kiuchi H, Imamura R, Uemura M,
       Fukuhara S, Morii E, Nonomura N.
         IJU Case Rep. 2021 May 27;4(4):255-258.

14. Clear Cell Carcinoma in the Oral Cavity with Three Novel Types of EWSR1-ATF1
      Translocation: A Case Report.

        Nojima S, Kohara M, Harada H, Kajikawa H, Hirose K, Nakatsuka SI, Nakagawa Y, Oya K,
        Fukuda Y, Matsunaga K, Uzawa N, Fujimoto M, Toyosawa S, Morii E.
          Head Neck Pathol. 2021 Jul 12. doi: 10.1007/s12105-021-01356-y. Online ahead of print.

13. Amyotrophic lateral sclerosis with speech apraxia, predominant upper motor neuron
      signs, and prominent iron accumulation in the frontal operculum and precentral
      gyrus.

       Mitani TT, Beck G, Kido K, Yamashita R, Yonenobu Y, Ogawa T, Saeki C, Okuno T, Nagano S,
       Morii E, Hasegawa M, Saito Y, Murayama S, Mochizuki H.
         Neuropathology. 2021 Aug;41(4):324-331.

12. Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced
      Liver Fibrosis.

        Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, Motooka D, Kakita N,
        Yamada Y, Kondo Y, Tahata Y, Yamada R, Hikita H, Sakamori R, Kamada Y, Daly AK,
        Anstee QM, Tatsumi T, Morii E, Takehara T.
          Hepatology. 2021 Nov;74(5):2452-2466.

11. An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic
      Stroke.

        Kitano T, Hori Y, Okazaki S, Shimada Y, Iwamoto T, Kanki H, Sugiyama S, Sasaki T,
        Nakamura H, Oyama N, Hoshi T, Beck G, Takai H, Matsubara S, Mizuno H, Nishimura H,
        Tamaki R, Iida J, Iba J, Uno M, Kishima H, Fushimi H, Hattori S, Murayama S, Morii E,
        Sakaguchi M, Yagita Y, Shimazu T, Mochizuki H, Todo K.
           Thromb Haemost. 2021 Jun 2. doi: 10.1055/a-1522-4507. Online ahead of print.

10. A deep learning system to diagnose the malignant potential of urothelial carcinoma
     cells in cytology specimens.

       Nojima S, Terayama K, Shimoura S, Hijiki S, Nonomura N, Morii E, Okuno Y, Fujita K.
         Cancer Cytopathol. 2021 May 12. doi: 10.1002/cncy.22443. Online ahead of print.

9. Primary Alveolar Soft Part Sarcoma of Cheek: Report of a Case and Review of the
    Literature.

     Hirose K, Naniwa K, Usami Y, Kohara M, Uchihashi T, Tanaka S, Yamada S, Iwamoto Y,
     Murakami S, Oya K, Fukuda Y, Hori Y, Morii E, Toyosawa S.
       Head Neck Pathol. 2021 Apr 11. doi: 10.1007/s12105-021-01324-6. Online ahead of print.

8. Identification of CXCL12-abundant reticular cells in human adult bone marrow.
     Aoki K, Kurashige M, Ichii M, Higaki K, Sugiyama T, Kaito T, Ando W, Sugano N, Sakai T,
     Shibayama H; HANDAI Clinical Blood Club, Takaori-Kondo A, Morii E, Kanakura Y, Nagasawa T.
      Br J Haematol. 2021 May;193(3):659-668.

7. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid
    differs genetically and epigenetically from Bcl-2-positive IGH-BCL2
    translocation-positive follicular lymphoma.

      Hamamoto Y, Kukita Y, Kitamura M, Kurashige M, Masaie H, Fuji S, Ishikawa J, Honma K,
      Wakasa T, Hanamoto H, Hirokawa M, Suzuki A, Morii E, Nakatsuka SI.
        Histopathology. 2021 Oct;79(4):521-532.

6. Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
     Takashima T, Taniyama D, Sakamoto N, Yasumoto M, Asai R, Hattori T, Honma R,
     Thang PQ, Ukai S, Maruyama R, Harada K, Kuraoka K, Tanabe K, Sasaki AT, Ohdan H,
     Morii E, Murai J, Yasui W.
       Br J Cancer. 2021 Jul;125(1):65-77.

5. An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells
    is related to an unfavorable prognosis.

     Kusumoto S, Kurashige M, Ohshima K, Tahara S, Matsui T, Nojima S, Hattori S, Morii E.
      Cancer Med. 2021 Mar;10(5):1485-1500.

4. Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue
    and its molecular mechanism.

     Ito N, Yamada M, Morishita K, Nojima S, Motooka K, Sakata N, Asuka T, Otsu R,
     Takamatsu S, Kamada Y, Mori S, Akita H, Eguchi H, Morii E, Miyoshi E.
       Glycoconj J. 2021 Feb;38(1):45-54.

3. Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell
    development.

     Moribe F, Nishikori M, Takashima T, Taniyama D, Onishi N, Arima H, Sasanuma H,
     Akagawa R, Elloumi F, Takeda S, Pommier Y, Morii E, Takaori-Kondo A, Murai J.
      PLoS One. 2021 Jan 29;16(1):e0237554.

2. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for
    evaluating endoscopic remission in ulcerative colitis.

      Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N,
      Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E.
        World J Gastroenterol. 2021 Jan 14;27(2):162-175.

1. Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.
     Ohshima K, Morii E.
       Metabolites. 2021 Jan 2;11(1):28. doi: 10.3390/metabo11010028.

2020 年

   
37. Resolution of Pancreatic Duct Dilatation After Resection of Main-Duct Intraductal
      Papillary Mucinous Neoplasm.

       Mori S, Tomimaru Y, Kobayashi S, Tahara S, Iwagami Y, Yamada D, Akita H, Noda T,
       Gotoh K, Morii E, Doki Y, Eguchi H.
         Am Surg. 2020 Dec 15:3134820973740. doi: 10.1177/0003134820973740.
         Online ahead of print.

36. The expression of trefoil factor 3 is related to histologic subtypes and invasiveness in
      lung adenocarcinoma.

        Luo W, Tahara S, Kawasaki K, Kobayashi A, Nojima S, Morii E.
          Oncol Lett. 2021 Jan;21(1):63.

35. Skull Base Metastasis of Breast Cancer With Oculomotor and Trochlear Nerve Palsy.
       Adachi K, Maeda Y, Hayama M, Kitaguchi Y, Nojima S, Nitta K, Obata S, Nakatani A, Tsuda T,
       Takeda K, Morii E, Inohara H.
         Ear Nose Throat J. 2020 Oct 9:145561320963676. doi: 10.1177/0145561320963676.
         Online ahead of print.

34. Impact of DNA integrity on the success rate of tissue-based next-generation
      sequencing: Lessons from nationwide cancer genome screening project SCRUM-Japan
      GI-SCREEN.

        Kuwata T, Wakabayashi M, Hatanaka Y, Morii E, Oda Y, Taguchi K, Noguchi M, Ishikawa Y,
        Nakajima T, Sekine S, Nomura S, Okamoto W, Fujii S, Yoshino T; SCRUM-Japan GI-SCREEN
        Pathology Group.
          Pathol Int. 2020 Dec;70(12):932-942.

33. Detection of Phosphorylated Alpha-Synuclein in the Muscularis Propria of the
      Gastrointestinal Tract Is a Sensitive Predictor for Parkinson's Disease.

        Beck G, Hori Y, Hayashi Y, Morii E, Takehara T, Mochizuki H.
         Parkinsons Dis. 2020 Sep 23;2020:4687530.

32. Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in
      Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by
      Surgery.

        Hagi T, Makino T, Yamasaki M, Yamashita K, Tanaka K, Saito T, Takahashi T, Kurokawa Y,
        Motoori M, Kimura Y, Nakajima K, Morii E, Eguchi H, Doki Y.
          Ann Surg. 2020 Jul 14. doi: 10.1097/SLA.0000000000004238. Online ahead of print.

31. A Potential Mechanism of Anticancer Immune Response Coincident With
     Immune-related Adverse Events in Patients With Renal Cell Carcinoma.

      Kato T, Tomiyama E, Koh Y, Matsushita M, Hayashi Y, Nakano K, Ishizuya YU, Wang C,
      Hatano K, Kawashima A, Ujike T, Kawasaki K, Morii E, Gotoh K, Eguchi H, Kiyotani K, Fujita K,
      Nonomura N, Uemura M.
        Anticancer Res. 2020 Sep;40(9):4875-4883.

30. Clear Cell Carcinoma of Palatal Minor Salivary Gland Harboring a Novel EWSR1-ATF1
      Fusion Gene: Report of a Case and Review of the Literature.

       Hirose K, Usami Y, Kohara M, Sato S, Iwamoto Y, Murakami S, Uchihashi T, Oya K, Fukuda Y,
       Hori Y, Morii E, Toyosawa S.
         Head Neck Pathol. 2021 Jun;15(2):676-681.

29. A case of repeat resection for recurrent pulmonary metastasis from sebaceous gland
      carcinoma.

       Kawagishi S, Kanzaki R, Taniguchi S, Kimura K, Kimura T, Takabatake H, Morii E, Inoue M,
       Shintani Y.
         Surg Case Rep. 2020 Aug 12;6(1):206.

28. A Case of Lymphocytic Myocarditis with Eosinophilic Degranulation Successfully
     Treated with Steroid Therapy.

      Inoue T, Sera F, Nishimura S, Nakamoto K, Tsukamoto Y, Mizote I, Ohtani T, Hikoso S,
      Ikeda Y, Hori Y, Ishibashi-Ueda H, Morii E, Minamino T, Sakata Y.
        Case Rep Cardiol. 2020 Jul 28;2020:8887726.

27. HTR3A is correlated with unfavorable histology and promotes proliferation through
      ERK phosphorylation in lung adenocarcinoma.

       Tone M, Tahara S, Nojima S, Motooka D, Okuzaki D, Morii E.
         Cancer Sci. 2020 Oct;111(10):3953-3961.

26. Nonlinear Optics with Near-Infrared Excitation Enable Real-Time Quantitative
      Diagnosis of Human Cervical Cancers.

       Matsui T, Tamoto R, Iwasa A, Mimura M, Taniguchi S, Hasegawa T, Sudo T, Mizuno H,
       Kikuta J, Onoyama I, Okugawa K, Shiomi M, Matsuzaki S, Morii E, Kimura T, Kato K,
       Kiyota Y, Ishii M.
        Cancer Res. 2020 Sep 1;80(17):3745-3754.

25. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the
      mammalian target of rapamycin (mTOR) pathway.

        Hori Y, Hirose K, Aramaki-Hattori N, Suzuki S, Nakayama R, Inoue M, Matsui T, Kohara M,
        Toyosawa S, Morii E.
          Diagn Pathol. 2020 Jul 25;15(1):98.

24. A Case of Endonasal Endoscopic Surgery for Intraorbital Metastasis of Gastric Ring
     Cell Carcinoma.

      Tsuruta Y, Maeda Y, Kitaguchi Y, Hayama M, Nojima S, Tsuda T, Takeda K, Nakatani A,
      Obata S, Morii E, Inohara H.
        Ear Nose Throat J. 2020 Jul 22:145561320943372.

23. Serine racemase enhances growth of colorectal cancer by producing pyruvate from
      serine.

       Ohshima K, Nojima S, Tahara S, Kurashige M, Kawasaki K, Hori Y, Taniguchi M, Umakoshi Y,
        Okuzaki D, Wada N, Ikeda JI, Fukusaki E, Morii E.
         Nat Metab. 2020 Jan;2(1):81-96.

22. PAX 8-positive sarcomatoid carcinoma arising from the liver with aggressive
      phenotype: 
An autopsy case.
        Ogata M, Ohshima K, Ichihara M, Takahashi H, Morii E.
         Pathol Int. 2020 Oct;70(10):825-827.

21. Detection of synovial sarcoma with an atypical fusion transcript by using SS18-SSX
      and SSX antibodies.

       Tahara S, Kohara M, Honma K, Morii E.
         Pathol Int. Sep;70(9):689-691.

20. TERT C228T mutation in non-malignant bladder urothelium is associated with
      intravesical recurrence for patients with non-muscle invasive bladder cancer.

        Hayashi Y, Fujita K, Nojima S, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C,
        Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Morii E,
        Nonomura N.
          Mol Oncol. 2020 Jun 13.

19. Usefulness of immunohistochemistry to distinguish between secretory carcinoma and
      acinic cell carcinoma in the salivary gland.

        Hamamoto Y, Harada H, Kohara M, Honma K, Nakatsuka SI, Morii E.
          Med Mol Morphol. 2020 Jun 1.

18. FAM111B enhances proliferation of KRAS-driven lung adenocarcinoma by degrading
      p16.

        Kawasaki K, Nojima S, Hijiki S, Tahara S, Ohshima K, Matsui T, Hori Y, Kurashige M,
        Umeda D, Kiyokawa H, Kido K, Okuzaki D, Morii E.
          Cancer Sci. 2020 Jul;111(7):2635-2646.

17. Peritumoral Lymphatic Vessels Associated with Resistance to Neoadjuvant
     Chemotherapy and Unfavorable Survival in Esophageal Cancer.

      Hara T, Makino T, Yamasaki M, Tanaka K, Yamashita K, Nogi Y, Saito T, Takahashi T,
      Kurokawa Y, Tatsumi M, Nakajima K, Morii E, Eguchi H, Doki Y.
        Ann Surg Oncol. 2020 Apr 23.

16. Tumour grade significantly correlates with total dysfunction of tumour
      tissue-infiltrating lymphocytes in renal cell carcinoma.

       Kawashima A, Kanazawa T, Kidani Y, Yoshida T, Hirata M, Nishida K, Nojima S, Yamamoto Y,
       Kato T, Hatano K, Ujike T, Nagahara A, Fujita K, Morimoto-Okazawa A, Iwahori K, Uemura M,
       Imamura R, Ohkura N, Morii E, Sakaguchi S, Wada H, Nonomura N.
         Sci Rep. 2020 Apr 10;10(1):6220.

15. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated
      Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic
      Lesions.

       Kojima F, Gandhi JS, Matsuzaki I, Iba A, Collier S, Yoshikawa T, Kinoshita Y, Warigaya K,
       Fujimoto M, Kuroda N, Morii E, Hara I, Murata SI, Amin MB.
         Am J Surg Pathol. 2020 Apr 7. doi: 10.1097/PAS.0000000000001482. Online ahead of print.

14. Japanese clinical practice guidelines for vascular anomalies 2017.
       Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, Nakaoka H, Morii E, Kuramochi A,
       Aoki Y, Arai Y, Aramaki N, Inoue M, Iwashina Y, Iwanaka T, Ueno S, Umezawa A, Ozeki M,
       Ochi J, Kinoshita Y, Kurita M, Seike S, Takakura N, Takahashi M, Tachibana T, Chuman K,
       Nagata S, Narushima M, Niimi Y, Nosaka S, Nozaki T, Hashimoto K, Hayashi A, Hirakawa S,
       Fujikawa A, Hori Y, Matsuoka K, Mori H, Yamamoto Y, Yuzuriha S, Rikihisa N, Watanabe S,
       Watanabe S, Kuroda T, Sugawara S, Ishikawa K, Sasaki S.
         Jpn J Radiol. 2020 Apr;38(4):287-342.

13. Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their
      immunosuppressive function.

        Nagate Y, Ezoe S, Fujita J, Okuzakis D, Motooka D, Ishibashi T, Ichii M, Tanimura A,
        Kurashige M, Morii E, Fukushima T, Suehiro Y, Yokota T, Shibayama H, Oritani K,
        Kanakura Y.
          Leukemia. 2020 Mar 20. doi: 10.1038/s41375-020-0788-y. Online ahead of print.

12. Japanese clinical practice guidelines for vascular anomalies 2017.
       Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, Nakaoka H, Morii E, Kuramochi A,
       Aoki Y, Arai Y, Aramaki N, Inoue M, Iwashina Y, Iwanaka T, Ueno S, Umezawa A, Ozeki M,
       Ochi J, Kinoshita Y, Kurita M, Seike S, Takakura N, Takahashi M, Tachibana T, Chuman K,
       Nagata S, Narushima M, Niimi Y, Nosaka S, Nozaki T, Hashimoto K, Hayashi A, Hirakawa S,
       Fujikawa A, Hori Y, Matsuoka K, Mori H, Yamamoto Y, Yuzuriha S, Rikihisa N, Watanabe S,
       Watanabe S, Kuroda T, Sugawara S, Ishikawa K, Sasaki S.
         Pediatr Int. 2020 Mar;62(3):257-304.

11. Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.
       Mimura H, Akita S, Fujino A, Jinnin M, Ozaki M, Osuga K, Nakaoka H, Morii E, Kuramochi A,
       Aoki Y, Arai Y, Aramaki N, Inoue M, Iwashina Y, Iwanaka T, Ueno S, Umezawa A, Ozeki M,
       Ochi J, Kinoshita Y, Kurita M, Seike S, Takakura N, Takahashi M, Tachibana T, Chuman K,
       Nagata S, Narushima M, Niimi Y, Nosaka S, Nozaki T, Hashimoto K, Hayashi A, Hirakawa S,
       Fujikawa A, Hori Y, Matsuoka K, Mori H, Yamamoto Y, Yuzuriha S, Rikihisa N, Watanabe S,
       Watanabe S, Kuroda T, Sugawara S, Ishikawa K, Sasaki S.
         J Dermatol. 2020 May;47(5):e138-e183.

10. Dysregulated Expression of the Nuclear Exosome Targeting Complex Component
      Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis.

       Fukushima K, Satoh T, Sugihara F, Sato Y, Okamoto T, Mitsui Y, Yoshio S, Li S, Nojima S,
       Motooka D, Nakamura S, Kida H, Standley DM, Morii E, Kanto T, Yanagita M, Matsuura Y,
       Nagasawa T, Kumanogoh A, Akira S.
         Immunity. 2020 Mar 17;52(3):542-556.e13.

9. Analysis of mTOR pathway expression in lymphatic malformation and related diseases.
     Hori Y, Ozeki M, Hirose K, Matsuoka K, Matsui T, Kohara M, Tahara S, Toyosawa S, Fukao T,
     Morii E.
       Pathol Int. 2020 Jun;70(6):323-329.

8. ARL4C is associated with initiation and progression of lung adenocarcinoma and
    represents a therapeutic target.

      Kimura K, Matsumoto S, Harada T, Morii E, Nagatomo I, Shintani Y, Kikuchi A.
       Cancer Sci. 2020 Mar;111(3):951-961.

7. A clinicopathological study of ALS with L126S mutation in the SOD1 gene presenting
    with isolated inferior olivary hypertrophy.

      Hideshima M, Beck G, Yamadera M, Motoyama Y, Ikenaka K, Kakuda K, Tsuda H, Nagano S,
      Fujimura H, Morii E, Murayama S, Mochizuki H.
        Neuropathology. 2020 Apr;40(2):191-195.

6. Marked Hypergastrinemia with G-cell Hyperplasia in Two Autoimmune Gastritis
    Patients.

      Watanabe H, Yoneda S, Motoyama Y, Mukai K, Okuno Y, Kozawa J, Nishizawa H, Maeda N,
      Otsuki M, Matsuoka TA, Morii E, Iwahashi H, Shimomura I.
       Intern Med. 2020 Mar 15;59(6):799-803.

5. Interstitial cells of Cajal are diminished in critically ill patients: Autopsy cases.
     Shimizu K, Ogura H, Matsumoto N, Ikeda M, Yamamoto H, Mori M, Morii E, Shimazu T.
       Nutrition. 2020 Feb;70:110591.

4. Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to
    Hepatocarcinogenesis in Mice.

      Kurahashi T, Yoshida Y, Ogura S, Egawa M, Furuta K, Hikita H, Kodama T, Sakamori R,
      Kiso S, Kamada Y, Wang IC, Eguchi H, Morii E, Doki Y, Mori M, Kalinichenko VV, Tatsumi T,
      Takehara T.
        Cell Mol Gastroenterol Hepatol. 2020;9(3):425-446.

3. Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary
    Hypertension and the Cardiac Function in a Patient with Myelofibrosis.

     Miyawaki H, Kioka H, Sato K, Kurashige M, Ozawa T, Shibayama H, Hikoso S, Morii E,
     Yamauchi-Takihara K, Sakata Y.
       Intern Med. 2020 Jan 15;59(2):229-233.

2. Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a
    suspected soft-tissue tumor.

     Okuno H, Tanaka H, Hagiya H, Yoshida H, Hamaguchi S, Hori Y, Morii E, Hamada K,
     Yoshikawa H, Tomono K.
       J Infect Chemother. 2020 Feb;26(2):261-264.

1. The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced
    Esophageal Cancer and Its Clinical Significance.

      Hashimoto T, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y,
      Motoori M, Kimura Y, Nakajima K, Morii E, Mori M, Doki Y.
        Ann Surg. 2020 May;271(5):875-884.
 
   

2019 年


15. Possible malignant transformation of arteriovenous malformation to angiosarcoma:
      case report and literature review.

        Tanaka Y, Seike S, Tomita K, Ikeda JI, Morii E, Isomura ET, Kubo T.
           J Surg Case Rep. 2019 Dec 23;2019(12):rjz375.

14. Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to
      Hepatocarcinogenesis in Mice.

        Kurahashi T, Yoshida Y, Ogura S, Egawa M, Furuta K, Hikita H, Kodama T, Sakamori R,
        Kiso S, Kamada Y, Wang IC, Eguchi H, Morii E, Doki Y, Mori M, Kalinichenko VV, Tatsumi T,
        Takehara T.
          Cell Mol Gastroenterol Hepatol. 2020;9(3):425-446.

13. Total thymectomy for thymic lymphoepithelioma-like carcinoma-report of two cases.
       Kawagishi S, Ose N, Minami M, Funaki S, Kanou T, Kimura K, Taniguchi S, Morii E, Shintani Y.          Surg Case Rep. 2019 Oct 26;5(1):158.

12. Late-Onset Central Nervous System Posttransplant Lymphoproliferative Disorder
      After Lung Transplantation:A Case Report.

        Ose N, Minami M, Funaki S, Kanou T, Fukui E, Morii E, Shintani Y.
          Transplant Proc. 2019 Nov;51(9):3163-3166.

11. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by
      suppressing TGFβ signaling.

        Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, Obika S,
        Takehara T, Morii E, Okuyama H, Kikuchi A.
           Nat Commun. 2019 Aug 28;10(1):3882.

10. Clinicopathological characteristics and survival of primary malignant melanoma of
      the esophagus.

        Hashimoto T, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y,
        Motoori M, Kimura Y, Nakajima K, Morii E, Mori M, Doki Y.
          Oncol Lett. 2019 Aug;18(2):1872-1880.

9. Application of deep learning (3-dimensional convolutional neural network) for the
    prediction of pathological invasiveness in lung adenocarcinoma: A preliminary study.

     Yanagawa M, Niioka H, Hata A, Kikuchi N, Honda O, Kurakami H, Morii E, Noguchi M,
     Watanabe Y, Miyake J, Tomiyama N.
       Medicine (Baltimore). 2019 Jun;98(25):e16119.

8. Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C α/δ
    (PKCα/δ) enhances cell motility.

     Mori Y, Akita K, Ojima K, Iwamoto S, Yamashita T, Morii E, Nakada H.
       J Biol Chem. 2019 Jul 26;294(30):11513-11524.

7. Laparoscopy-assisted extended right hepatectomy for giant hemorrhagic hepatic cyst
    mimicking biliary cystadenocarcinoma: a case report.

     Fukuda Y, Asaoka T, Eguchi H, Honma K, Morii E, Iwagami Y, Akita H, Noda T, Gotoh K,
     Kobayashi S, Mori M, Doki Y.
       Surg Case Rep. 2019 Apr 11;5(1):58.

6. Serum deprivation-response protein regulates aldehyde dehydrogenase 1 through
    integrin-linked kinase signaling in endometrioid carcinoma cells.

     Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Motoyama Y, Okuzaki D,
     Ikeda JI, Morii E.
      Cancer Sci. 2019 May;110(5):1804-1813.

5. Radiotherapy alone as a possible de-intensified treatment for human
    papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.

     Yamamoto Y, Takemoto N, Michiba T, Seo Y, Isohashi F, Otani K, Suzuki M, Fujii T, Yoshii T,
     Mitani K, Yasui T, Cho H, Tomita Y, Morii E, Teshima T, Ogawa K, Inohara H.
       Int J Clin Oncol. 2019 Jun;24(6):640-648.

4. A fatal case of Exophiala dermatitidis disseminated infection in an allogenic
    hematopoietic stem cell transplant recipient during micafungin therapy.

     Hagiya H, Maeda T, Kusakabe S, Kawasaki K, Hori Y, Kimura K, Ueda A, Yoshioka N, Sunada A,
     Nishi I, Morii E, Kanakura Y, Tomono K.
       J Infect Chemother. 2019 Jun;25(6):463-466.

3. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and
    Metastatic Liver Tumor Growth.

     Harada T, Matsumoto S, Hirota S, Kimura H, Fujii S, Kasahara Y, Gon H, Yoshida T, Itoh T,
     Haraguchi N, Mizushima T, Noda T, Eguchi H, Nojima S, Morii E, Fukumoto T, Obika S,
     Kikuchi A.
       Mol Cancer Ther. 2019 Mar;18(3):602-612.

2. Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral
    Glucose Load.

     Mukai K, Otsuki M, Tamada D, Kitamura T, Hayashi R, Saiki A, Goto Y, Arita H, Oshino S,
     Morii E, Saitoh Y, Shimomura I.
       J Clin Endocrinol Metab. 2019 May 1;104(5):1637-1644.

1.  Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant
     Chemotherapy for Middle and Lower Thoracic Esophageal Cancer.

      Miyata H, Sugimura K, Yamasaki M, Makino T, Tanaka K, Morii E, Omori T, Yamamoto K,
      Yanagimoto Y, Yano M, Nakatsuka S, Mori M, Doki Y.
        Ann Surg Oncol. 2019 Jan;26(1):200-208.
   
     

2018 年


32. Cascade Reaction in Human Live Tissue Allows Clinically Applicable Diagnosis of
      Breast Cancer Morphology.

       Tanei T, Pradipta AR, Morimoto K, Fujii M, Arata M, Ito A, Yoshida M, Saigitbatalova E,
       Kurbangalieva A, Ikeda JI, Morii E, Noguchi S, Tanaka K.
         Adv Sci (Weinh). 2018 Nov 27;6(2):1801479.

31. Eukaryotic translation initiation factor 3 subunit C is associated with acquired
      resistance to erlotinib in non-small cell lung cancer.

       Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, Kashiwagi Y, Sato A,
       Obana M, Yamamoto A, Kawasaki K, Lin Y, Kijima T, Kinehara Y, Miwa Y, Maeda S, Morii E,
       Kumanogoh A, Tsutsumi Y, Nagatomo I, Fujio Y.
          Oncotarget. 2018 Dec 25;9(101):37520-37533.

30. Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar
     Protein Expression Profiles.

      Egawa-Takata T, Yoshino K, Hiramatsu K, Nakagawa S, Serada S, Nakajima A, Endo H,
      Kubota S, Matsuzaki S, Kobayashi E, Ueda Y, Morii E, Inoue M, Naka T, Kimura T.
        Int J Gynecol Cancer. 2018 Nov;28(9):1751-1757.

29. Origin of cancer-associated fibroblasts and tumor-associated macrophages in
      humans after sex-mismatched bone marrow transplantation.

        Kurashige M, Kohara M, Ohshima K, Tahara S, Hori Y, Nojima S, Wada N, Ikeda JI,
        Miyamura K, Ito M, Morii E.
          Commun Biol. 2018 Sep 3;1:131.

28. A case of ectopic ACTH syndrome due to DDAVP-sensitive but V1b receptor-negative
      bronchial typical carcinoid with lymphatic metastasis and plasma ProGRP elevation.

       Yamamuro T, Inoue K, Nagai Y, Azuma D, Yamamoto A, Hara K, Kohara M, Iwata T,
       Nakatsuka S, Morii E, Yamamoto T.
         Endocr J. 2018 Dec 28;65(12):1161-1169.

27. p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation
      via CKAP4.

        Kajiwara C, Fumoto K, Kimura H, Nojima S, Asano K, Odagiri K, Yamasaki M, Hikita H,
        Takehara T, Doki Y, Morii E, Kikuchi A.
          Cancer Res. 2018 Nov 1;78(21):6107-6120.

26. Effect of glutamine on lymphoplasmacytic lymphoma, especially on the viewpoint of
      the differentiation into vulnerable subpopulation.

        Wada N, Nojima S, Tahara SI, Ohshima K, Kurashige M, Kawasaki K, Tone M, Kusumoto S,
        Ikeda JI, Morii E.
          Pathol Res Pract. 2018 Oct;214(10):1667-1674.

25. Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents.
      Tainaka K, Murakami TC, Susaki EA, Shimizu C, Saito R, Takahashi K, Hayashi-Takagi A,
      Sekiya H, Arima Y, Nojima S, Ikemura M, Ushiku T, Shimizu Y, Murakami M, Tanaka KF,
      Iino M, Kasai H, Sasaoka T, Kobayashi K, Miyazono K, Morii E, Isa T, Fukayama M, Kakita A,
      Ueda HR.
        Cell Rep. 2018 Aug 21;24(8):2196-2210.e9.

24. STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.
       Matsuzaki K, Fujita K, Hayashi Y, Matsushita M, Nojima S, Jingushi K, Kato T, Kawashima A,
       Ujike T, Nagahara A, Uemura M, Imamura R, Yamaguchi S, Fushimi H, Miyamoto H, Morii E,
       Nonomura N.
         PLoS One. 2018 Aug 9;13(8):e0201256.

23. Glucose Intolerance After Pancreatectomy Was Associated With Preoperative
     Hemoglobin A1c, Insulin Resistance, and Histological Pancreatic Fatty Infiltration.

       Ishibashi C, Kozawa J, Fujita Y, Yoneda S, Uno S, Kimura T, Fukui K, Nojima S, Morii E,
       Eguchi H, Iwahashi H, Imagawa A, Shimomura I.
         Pancreas. 2018 Sep;47(8):e48-e50.

22. CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic
      Stellate Cells to Accelerate HCC Progression.

        Makino Y, Hikita H, Kodama T, Shigekawa M, Yamada R, Sakamori R, Eguchi H, Morii E,
        Yokoi H, Mukoyama M, Hiroshi S, Tatsumi T, Takehara T.
          Cancer Res. 2018 Sep 1;78(17):4902-4914.

21. Histological changes of superficial esophageal squamous cell carcinoma after
      preoperative chemotherapy.

        Sugase T, Makino T, Yamasaki M, Tanaka K, Hashimoto T, Miyazaki Y, Takahashi T,
         Kurokawa Y, Nakajima K, Mano M, Morii E, Mori M, Doki Y.
           Esophagus. 2018 Jun 16.

20. Persistent methicillin-resistant Staphylococcus aureus bacteremia owing to placental
      abscess.

        Maeda N, Hagiya H, Takiuchi T, Kusakabe S, Maeda T, Kimura K, Iwai S, Kawasaki K, Hori Y,
        Morii E, Kanakura Y, Kimura T, Tomono K.
           J Infect Chemother. 2018 Dec;24(12):975-979.

19. High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6
      Signaling.

        Hayashi T, Fujita K, Nojima S, Hayashi Y, Nakano K, Ishizuya Y, Wang C, Yamamoto Y,
        Kinouchi T, Matsuzaki K, Jingushi K, Kato T, Kawashima A, Nagahara A, Ujike T, Uemura M,
        Pena MDCR, Gordetsky JB, Morii E, Tsujikawa K, Netto GJ, Nonomura N.
          Clin Cancer Res. 2018 Sep 1;24(17):4309-4318.

18. Adenoma of colorectal laterally spreading tumor nongranular type with biological
      phenotypic features similar to cancer.

        Nagai K, Hayashi Y, Honma K, Sakatani A, Yoshii S, Fujinaga T, Maekawa A, Tsujii Y,
        Hiyama S, Shinzaki S, Watabe K, Iijima H, Tsujii M, Mizushima T, Morii E, Takehara T.
           J Gastroenterol Hepatol. 2018 Nov;33(11):1853-1863.

17. The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying
     Tumor-Related Leukocytosis: Clinical and Preclinical Investigations.

       Sasano T, Mabuchi S, Kozasa K, Kuroda H, Kawano M, Takahashi R, Komura N, Yokoi E,
       Matsumoto Y, Hashimoto K, Sawada K, Morii E, Kimura T.
         Clin Cancer Res. 2018 Aug 15;24(16):4018-4029.

16. The Impact of Pathological Tumor Regression and Nodal Status on Survival and
     Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal
     Squamous Cell Carcinoma.

      Miyata H, Tanaka K, Makino T, Yamasaki M, Miyazaki Y, Takahashi T, Kurokawa Y,
      Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y.
        Ann Surg Oncol. 2018 Aug;25(8):2409-2417.

15. A case report of granulomatous amoebic encephalitis by Group 1 Acanthamoeba
     genotype T18 diagnosed by the combination of morphological examination and genetic
     analysis.

      Matsui T, Maeda T, Kusakabe S, Arita H, Yagita K, Morii E, Kanakura Y.
        Diagn Pathol. 2018 May 10;13(1):27.

14. Middle segment pancreatectomy for a solid serous cystadenoma diagnosed by MRCP
      and review of the literature: A case report.

       Okumura Y, Noda T, Eguchi H, Iwagami Y, Yamada D, Asaoka T, Kawamoto K, Gotoh K,
       Kobayashi S, Umeshita K, Hashimoto Y, Takeda Y, Tanemura M, Shigekawa M, Morii E,
       Takehara T, Mori M, Doki Y.
         Mol Clin Oncol. 2018 May;8(5):675-682.

13. A case of severe soft tissue infection due to Streptococcus tigurinus diagnosed by
     necropsy in which genomic analysis was useful for clarifying its pathogenicity.

      Yoshizawa H, Motooka D, Matsumoto Y, Katada R, Nakamura S, Morii E, Iida T, Matsumoto H.
        Pathol Int. 2018 May;68(5):301-306. 

12. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing
     killer cell lectin-like receptor C3 expression by fumarate.

       Park H, Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, Okuzaki D, Wada N,
       Ikeda JI, Morii E.
         Lab Invest. 2018 Apr;98(4):449-461.

11. Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast
      with special reference to cellular components.
       Mishima C, Kagara N, Ikeda JI, Morii E, Miyake T, Tanei T, Naoi Y, Shimoda M, Shimazu K,
       Kim SJ, Noguchi S.
         Am J Pathol. 2018 May;188(5):1106-1112.

10. WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.
       Oji Y, Inoue M, Takeda Y, Hosen N, Shintani Y, Kawakami M, Harada T, Murakami Y,
       Iwai M, Fukuda M, Nishida S, Nakata J, Nakae Y, Takashima S, Shirakata T, Nakajima H,
       Hasegawa K, Kida H, Kijima T, Morimoto S, Fujiki F, Tsuboi A, Morii E, Morita S,
       Sakamoto J, Kumanogoh A, Oka Y, Okumura M, Sugiyama H.
         Int J Cancer.  2018 Jun 1;142(11):2375-2382.

9.  Whole exome sequencing demonstrates recurrent somatic copy number alterations
      and sporadic mutations in specialized stromal tumors the prostate.
       Pan CC, Tsuzuki T, Morii E, Fushimi H, Chen PC, Epstein JI.
         Hum Pathol. 2018 Jun;76:9-16.

8.  Usefulness of cytological analysis in the diagnosis of pancreatic undifferentiated
      rhabdoid carcinoma..

       Tahara S, Takeyari M, Morii E.
         Pathol Int. 2018 Jan;68(1):56-58.

7.   Enchondromatosis-associated oligodendroglioma: case report and literature review.
       Achiha T, Arita H, Kagawa N, Murase T, Ikeda JI, Morii E, Kanemura Y, Fujimoto Y,
       Kishima H.
         Brain Tumor Pathol. 2018 Jan;35(1):36-40.

6.   LSR antibody therapy inhibits ovarian epithelial tumor growth by inhibiting lipid
      uptake..

       Hiramatsu K, Serada S, Enomoto T, Takahashi Y, Nakagawa S, Nojima S, Morimoto A,
       Matsuzaki S, Yokoyama T, Takahashi T, Fujimoto M, Takemori H, Ueda Y, Yoshino K,
       Morii E, Kimura T, Naka T.
         Cancer Res. 2018 Jan 15;78(2):516-527.

5.   Motivating Mothers to Recommend Their 20-Year-Old Daughters Receive Cervical
      Cancer Screening: A Randomized Study.

       Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, Ohmichi M, Ichimura T,
       Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K,
       Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Asai-Sato M, Miyagi E, Sekine M,
       Enomoto T, Horikoshi Y, Takagi T, Shimura K.
         J Epidemiol. 2018 Mar 5;28(3):156-160.

4.  Incidence of gastric adenocarcinoma among lesions diagnosed as low-grade
     adenoma/dysplasia on endoscopic biopsy: A multicenter, prospective, observational
     study.

       Maekawa A, Kato M, Nakamura T, Komori M, Yamada T, Yamamoto K, Ogiyama H,
       Nakahara M, Kawai N, Yabuta T, Mukai A, Hayashi Y, Nishida T, Iijima H, Tsujii M, Morii E,
       Takehara T.
         Dig Endosc. 2018 Mar;30(2):228-235.

3.   A Case of Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic
      Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
       Takasugi J, Shimamura M, Koda T, Kishikawa T, Hanamoto A, Inohara H, Sato K, Morii E,
       Motomura M, Sakaguchi M, Nakatsuji Y, Mochizuki H.
         Intern Med. 2018 Feb 15;57(4):587-590.

2.  Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity
      against glypican-1 positive uterine cervical cancer.

       Matsuzaki S, Serada S, Hiramatsu K, Nojima S, Matsuzaki S, Ueda Y, Ohkawara T, Mabuchi S,
       Fujimoto M, Morii E, Yoshino K, Kimura T, Naka T.
         Int J Cancer. 2018 Mar 1;142(5):1056-1066.

1.  Results of treatment for thymic neuroendocrine tumours: multicentre
     clinicopathological study.

       Ose N, Maeda H, Inoue M, Morii E, Shintani Y, Matsui H, Tada H, Tokunaga T, Kimura K,
       Sakamaki Y, Takeuchi Y, Fukuhara K, Katsura H, Iwasaki T, Okumura M;
        for Thoracic Surgery Study Group of Osaka University.
         Interact Cardiovasc Thorac Surg. 2018 Jan 1;26(1):18-24.

  

2017 年


26. Detection of epidermal growth factor receptor mutations in lung adenocarcinoma
      cytological specimens by immunocytochemistry.
       Yoshida M, Nagatomo T, Ohnishi T, Kawashima M, Naitoh A, Morii E.
         Mol Clin Oncol. 2017 Dec;7(6):981-987.

25. [A Case of Adrenal Leiomyosarcoma]..
       Taniguchi A, Ujike T, Fujita K, Uemura M, Kiuchi H, Imamura R, Miyagawa Y, Nonomura N,
       Morii E.
         Hinyokika Kiyo. 2017 Nov;63(11):465-469. Japanese.

24. ALDH enzyme activity is regulated by Nodal and histamine in the A549 cell line.
       Jiang Y, Li H, Wang Y, Tian T, He Y, Jin Y, Han C, Jin X, Zhang F, Morii E.
         Oncol Lett. 2017 Dec;14(6):6955-6961.

23. The activated conformation of integrin β7 is a novel multiple myeloma-specific
      target for CAR T cell therapy.

       Hosen N, Matsunaga Y, Hasegawa K, Matsuno H, Nakamura Y, Makita M, Watanabe K,
       Yoshida M, Satoh K, Morimoto S, Fujiki F, Nakajima H, Nakata J, Nishida S, Tsuboi A,
       Oka Y, Manabe M, Ichihara H, Aoyama Y, Mugitani A, Nakao T, Hino M, Uchibori R,
       Ozawa K, Baba Y, Terakura S, Wada N, Morii E, Nishimura J, Takeda K, Oji Y, Sugiyama H,
       Takagi J, Kumanogoh A.
         Nat Med. 2017 Dec;23(12):1436-1443.

22. High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor
     Response to Chemotherapy and a Poor Prognosis for Patients Treated with
     Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

       Yamashita K, Miyata H, Makino T, Masuike Y, Furukawa H, Tanaka K, Miyazaki Y,
       Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y.
         Ann Surg Oncol. 2017 Dec; 24(13):4025-4032.

21. Chondroblastoma of extra-craniofacial bones: Clinicopathological analyses of
      103 cases..

       Konishi E, Nakashima Y, Mano M, Tomita Y, Kubo T, Araki N, Morii E, Yoshikawa H, Haga H,
       Toguchida J, Ueda T, Osawa M, Hoshi M, Inoue T, Aono M, Yanagisawa A.
         Pathol Int. 2017 Oct; 67(10):495-502. 

20. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian
     cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits
     ovarian cancer peritoneal dissemination.

       Nakatsuka E, Sawada K, Nakamura K, Yoshimura A, Kinose Y, Kodama M, Hashimoto K,
       Mabuchi S, Makino H, Morii E, Yamaguchi Y, Yanase T, Itai A, Morishige KI, Kimura T.
         Oncotarget. 2017 Sep 12;8(52):89887-89902. 

19. Whole-Genome Sequence of Streptococcus tigurinus Strain osk_001, Isolated from
      Postmortem Material.

       Yoshizawa H, Motooka D, Katada R, Matsumoto Y, Nakamura S, Morii E, Iida T,
       Matsumoto H.
         Genome Announc. 2017 Aug 31;5(35).

18. Whole-Genome Sequence of Streptococcus tigurinus Strain osk_001, Isolated from
      Postmortem Material.

       Yoshizawa H, Motooka D, Katada R, Matsumoto Y, Nakamura S, Morii E, Iida T,
       Matsumoto H.
         Genome Announc. 2017 Aug 31;5(35). 

17. Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a
      predictive factor of adverse pathology in radical prostatectomy specimens.
       Hayashi T, Fujita K, Nojima S, Hayashi Y, Nakano K, Ishizuya Y, Wang C, Yamamoto Y,
       Kinouchi T, Matsuzaki K, Kawamura N, Jingushi K, Kawashima A, Nagahara A, Ujike T,
       Uemura M, Imamura R, Morii E, Nonomura N.
         Prostate. 2017 Oct;77(14):1383-1388.

16. CUBIC pathology: three-dimensional imaging for pathological diagnosis.
       Nojima S, Susaki EA, Yoshida K, Takemoto H, Tsujimura N, Iijima S, Takachi K, Nakahara Y,  
       Tahara S, Ohshima K, Kurashige M, Hori Y, Wada N, Ikeda JI, Kumanogoh A, Morii E#,
       Ueda HR#. (#co-corresponding author)
         Sci Rep. 2017 Aug 24;7(1):9269. doi: 10.1038/s41598-017-09117-0.

15. Non-labeling multiphoton excitation microscopy as a novel diagnostic tool for
      discriminating normal tissue and colorectal cancer lesions.

        Matsui T, Mizuno H, Sudo T, Kikuta J, Haraguchi N, Ikeda JI, Mizushima T, Yamamoto H,
        Morii E, Mori M, Ishii M.
          Sci Rep. 2017 Jul 31;7(1):6959. doi: 10.1038/s41598-017-07244-2.

14. Massive tumor embolism in the abdominal aorta from pulmonary squamous cell
      carcinoma: Case report and review of the literature.
       Ohshima K, Tsujii Y, Sakai K, Oku H, Morii E.
          Pathol Int. 2017 Sep;67(9):467-471.

13. Effect of plasma-activated medium on the decrease of tumorigenic population in
     lymphoma.
      Wada N, Ikeda JI, Tanaka H, Sakakita H, Hori M, Ikehara Y, Morii E.
         Pathol Res Pract. 2017 Jul;213(7):773-777.

12. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity
      against esophageal squamous cell carcinoma.

       Harada E, Serada S, Fujimoto M, Takahashi Y, Takahashi T, Hara H, Nakatsuka R, Sugase T,
       Nishigaki T, Saito Y, Hiramatsu K, Nojima S, Mitsuo R, Ohkawara T, Morii E, Mori M, Doki Y,
       Kaneda Y, Naka T.
         Oncotarget. 2017 Apr 11;8(15):24741-24752.

11. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of
      neutrophil-mediated autoimmune vasculitis.
       Nishide M, Nojima S, Ito D, Takamatsu H, Koyama S, Kang S, Kimura T, Morimoto K,
       Hosokawa T, Hayama Y, Kinehara Y, Kato Y, Nakatani T, Nakanishi Y, Tsuda T, Park JH,
       Hirano T, Shima Y, Narazaki M, Morii E, Kumanogoh A.
         Ann Rheum Dis. 2017 Aug;76(8):1440-1448.

10. Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important
      Clinical Entity.

       Takasugi J, Sakaguchi M, Oyama N, Gon Y, Terasaki Y, Sasaki T, Nakahara S, Ohshima K,
       Hori Y, Morii E, Mochizuki H.
         J Stroke Cerebrovasc Dis. 2017 Jun;26(6):e108-e110.

9. Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine
    through Decreased DEPTOR Expression in Endometrial Cancer.

       Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, Hagiwara K, Okuzaki D, Oki S, Wada N,
       Ikeda JI, Kanai Y, Morii E.
          Sci Rep. 2017 Mar 30;7:45504. doi: 10.1038/srep45504.

8.  Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell
     lymphoma with the MYD88L265P mutation.

        Kida T, Tanimura A, Ono A, Matsui T, Honma K, Fujita J, Maeda T, Shibayama H, Oritani K,
        Morii E, Kanakura Y.
           Rinsho Ketsueki. 2017;58(2):155-160.

7.  Radiological prediction of tumor invasiveness of lung adenocarcinoma on
     thin-section CT.

       Yanagawa M, Johkoh T, Noguchi M, Morii E, Shintani Y, Okumura M, Hata A, Fujiwara M,
       Honda O, Tomiyama N.
           Medicine (Baltimore). 2017 Mar;96(11):e6331.

6.  Realistic fear of cervical cancer risk in Japan depending on birth year.
       Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, Terai Y, Ohmichi M,
       Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E,
       Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa A,
       Asai-Sato M, Miyagi E, Yamaguchi M, Kudoh R, Adachi S, Sekine M, Enomoto T, Horikoshi Y,
       Takagi T, Shimura K.
            Hum Vaccin Immunother. 2017 Mar 8:0.

5.  Two cases of resectable pancreatic cancer diagnosed by open surgical biopsy after
     endoscopic ultrasound fine-needle aspiration failed to yield diagnosis: case reports.
       Toshiyama R, Noda T, Eguchi H, Iwagami Y, Yamada D, Asaoka T, Wada H, Kawamoto K,
       Gotoh K, Takeda Y, Tanemura M, Morii E, Umeshita K, Mori M, Doki Y.
          Surg Case Rep. 2017 Dec;3(1):39.  

4.  An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various
     B-cell markers..

       Nakatsuka SI, Yutani C, Kurashige M, Kohara M, Nagano T, Goto T, Takatsuka H, Ifuku H,
       Morii E.
          Diagn Pathol. 2017 Jan 31;12(1):15.  

3.  Heterogeneity of tumor cells in terms of cancer-initiating cells.
       Morii E.
          J Toxicol Pathol. 2017 Jan;30(1):1-6. 

3.  Homology analysis detects topological changes of Iba1 localization accompanied by
     microglial activation.

       Sawano T, Tsuchihashi R, Morii E, Watanabe F, Nakane K, Inagaki S.
          Neuroscience. 2017 Mar 27;346:43-51. 

2.  Podocalyxin influences malignant potential by controlling epithelial mesenchymal
     transition in lung adenocarcinoma.

       Kusumoto H, Shintani Y, Kanzaki R, Kawamura T, Funaki S, Minami M, Nagatomo I, Morii E#,
       Okumura M. (#corresponding author)
          Cancer Sci. 2016 Dec 22. doi: 10.1111/cas.13142. [Epub ahead of print] 

1.  Pancreatic Neuroendocrine Tumor Abnormally Secreting Procalcitonin.
       Hagiya H, Matsui T, Kitamura T, Inoue T, Shigekawa M, Yoshida H, Morii E, Tomono K.
          Pancreas. 2017 Jan;46(1):e7-e9.
 

2016 年


28. Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and
     cyclin G2.

       Ohno S*, Ikeda JI*, Naito Y*, Okuzaki D, Sasakura T, Fukushima K, Nishikawa Y, Ota K,
       Kato Y, Wang M, Torigata K, Kasama T, Uchihashi T, Miura D, Yabuta N, Morii E#,
       Nojima H#.   (*co-first author, #co-corresponding author)
          Sci Rep. 2016 Dec 16;6:39091. doi: 10.1038/srep39091.

27. Gnathic giant cell-rich conventional osteosarcoma with MDM2 and CDK4 gene
      amplification.

        Hirose K, Okura M, Sato S, Murakami S, Ikeda JI, Noda Y, Fukuda Y, Morii E, Toyosawa S.
           Histopathology. 2016 Dec 7. doi: 10.1111/his.13141. [Epub ahead of print]

26. ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1
      in Hodgkin's lymphoma.

        Ikeda JI, Wada N, Nojima S, Tahara S, Tsuruta Y, Oya K, Morii E.
           Mol Clin Oncol. 2016 Nov;5(5):562-566.

25. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated
      region, promotes tumorigenesis of lung squamous cell carcinoma.
        Fujii S, Shinjo K, Matsumoto S, Harada T, Nojima S, Sato S, Usami Y, Toyosawa S, Morii E,
        Kondo Y, Kikuchi A.
           Oncotarget. 2016 Nov 7. doi: 10.18632/oncotarget.13147. [Epub ahead of print]

24. A case of gastric mixed adenoneuroendocrine carcinoma with difficulty in diagnosis
      before endoscopic submucosal dissection.
        Sakatani A, Shinzaki S, Hayashi Y, Maekawa A, Hiyama S, Yakushijin T, Tatsumi T,
        Iijima H, Hiramatsu N, Morii E, Takehara T.
           Nihon Shokakibyo Gakkai Zasshi. 2016;113(11):1909-1915.

23. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in
      Ulcerative Colitis.

        Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N,
        Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T.
           J Crohns Colitis. 2016 Jul 27. pii: jjw132. [Epub ahead of print]

22. A case report of pancreatic metastasis from synovial sarcoma successfully treated
      by metastasectomy with adjuvant chemotherapy.
        Makino Y, Shigekawa M, Kegasawa T, Suda T, Yoshioka T, Iwahashi K, Ikezawa K,
        Sakamori R, Yakushijin T, Kajihara J, Tomimaru Y, Eguchi H, Imura Y, Outani H, Naka N,
        Honma K, Morii E, Tatsumi T, Hiramatsu N, Takehara T.
           Medicine (Baltimore). 2016 Sep;95(39):e4789. doi: 10.1097/MD.0000000000004789.

21. Immunohistochemical analysis of the novel marginal-zone B-cell marker IRTA1 in
      malignant lymphoma..

        Ikeda JI, Kohara M, Tsuruta Y, Nojima S, Tahara S, Ohshima K, Kurashige M, Wada N,
        Morii E.
           Hum Pathol. 2016 Sep 22. doi: 10.1016/j.humpath.2016.09.011. [Epub ahead of print] 

20. Project conducted in Hirakata to improve cervical cancer screening rates in
     20-year-old Japanese: Influencing parents to recommend that their daughters
      undergo cervical cancer screening.
        Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Terai Y, Ohmichi M, Ichimura T, Sumi T,
        Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T,
        Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa A, Asai-Sato M,
        Miyagi E, Yamaguchi M, Kudo R, Adachi S, Sekine M, Enomoto T, Horikoshi Y, Takagi T,
        Shimura K.
           J Obstet Gynaecol Res. 2016 Sep 19. doi: 10.1111/jog.13122. [Epub ahead of print]

19. S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is
     associated with the 'MELF' pattern.

        Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Ikeda JI, Morii E.
           Cancer Sci. 2016 Sep;107(9):1345-52.

18. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate
      cancer.

        Fujita K, Hayashi T, Matsuzaki K, Nakata W, Masuda M, Kawashima A, Ujike T, Nagahara A,
        Tsuchiya M, Kobayashi Y, Nojima S, Uemura M, Morii E, Miyoshi E, Nonomura N.
           Oncotarget. 2016 Aug 1. doi: 10.18632/oncotarget.10987. [Epub ahead of print]

17. Dual-energy dynamic CT of lung adenocarcinoma: correlation of iodine uptake with
      tumor gene expression.

        Yanagawa M, Morii E, Hata A, Fujiwara M, Gyobu T, Ueda K, Honda O, Tomiyama N.
           Eur J Radiol. 2016 Aug;85(8):1407-13.

16. S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is
     associated with the 'MELF' pattern.

        Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Ikeda JI, Morii E.
           Cancer Sci. 2016 Sep;107(9):1345-52.

15. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression.
        Kimura H, Fumoto K, Shojima K, Nojima S, Osugi Y, Tomihara H, Eguchi H, Shintani Y,
        Endo H, Inoue M, Doki Y, Okumura M, Morii E, Kikuchi A.
           J Clin Invest. 2016 Jul 1;126(7):2689-705.

14. Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell
     transplantation: important histological component of late-onset noninfectious
     pulmonary complication accompanied with recurrent pneumothorax.

        Matsui T, Maeda T, Kida T, Fujita J, Tsuji H, Morii E, Kanakura Y.
           Int J Hematol. 2016 Oct;104(4):525-30.

13. Overexpression of glypican-1 implicates poor prognosis and their chemoresistance
      in oesophageal squamous cell carcinoma.

         Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E,
         Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M,
         Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.
            Br J Cancer. 2016 Jun 28;115(1):66-75.

12. Prognostic significance of a component of the Hippo pathway, TAZ, in human uterine
      endometrioid adenocarcinoma.

         Zhan M, Ikeda JI, Wada N, Hori Y, Nojima S, Tahara SI, Ueda Y, Yoshino K, Kimura T,
         Morii E.
           Oncol Lett. 2016 Jun;11(6):3611-3616.

11. The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of
      lymph node metastasis in patients with non-small cell lung cancer (NSCLC):
      Results of a multicenter prospective study.

         Nakagawa K, Asamura H, Tsuta K, Nagai K, Yamada E, Ishii G, Mitsudomi T, Ito A,
         Higashiyama M, Tomita Y, Inoue M, Morii E, Matsuura N, Okumura M.
            Lung Cancer. 2016 Jul;97:1-7.

10. Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human
      Vascular Lesions.

         Zhan M, Hori Y, Wada N, Ikeda J, Hata Y, Osuga K, Morii E.
            Acta Histochem Cytochem. 2016 Apr 28;49(2):75-81.

9.  Pheochromocytoma complicated by cyanotic congenital heart disease: a case report.
       Yamamoto K, Namba N, Kubota T, Usui T, Takahashi K, Kitaoka T, Fujiwara M, Hori Y,
       Kogaki S, Oue T, Morii E, Ozono K.
          Clin Pediatr Endocrinol. 2016 Apr;25(2):59-65.

8.  Nur77 gene expression levels were involved in different ACTH-secretion autonomy
     between Cushing's disease and subclinical Cushing's disease.

        Tabuchi Y, Kitamura T, Fukuhara A, Mukai K, Onodera T, Miyata Y, Hamasaki T, Oshino S,             Saitoh Y, Morii E, Otsuki M, Shimomura I.
           Endocr J. 2016 Jun 30;63(6):545-54.

7.  Intrahepatic cholangiocarcinoma in a patient with Wilson's disease: a case report.
       Mukai Y, Wada H, Eguchi H, Yamada D, Asaoka T, Noda T, Kawamoto K, Gotoh K, Takeda Y,
       Tanemura M, Umeshita K, Hori Y, Morii E, Doki Y, Mori M.
          Surg Case Rep. 2016 Dec;2(1):29.

6.  Similar protein expression profiles of ovarian and endometrial high-grade serous
     carcinomas.

       Hiramatsu K, Yoshino K, Serada S, Yoshihara K, Hori Y, Fujimoto M, Matsuzaki S,
       Egawa-Takata T, Kobayashi E, Ueda Y, Morii E, Enomoto T, Naka T, Kimura T.
          Br J Cancer. 2016 Mar 1;114(5):554-61.

5.  Requirement of CXCL12-CXCR7 signaling for CD20- CD138- double-negative population
     in lymphoplasmacytic lymphoma.
        Wada N, Ikeda JI, Nojima S, Tahara SI, Ohshima K, Okuzaki D, Morii E.
          Lab Invest.  2016 May;96(5):517-25.

4.  Induction of eEF2-specific antitumor CTL responses in vivo by vaccination with
     eEF2-derived 9mer-peptides.
        Nakajima H, Murakami Y, Morii E, Akao T, Tatsumi N, Odajima S, Fukuda M, Machitani T,
        Iwai M, Kawata S, Hojo N, Oka Y, Sugiyama H, Oji Y.
          Oncol Rep.  2016 Jan 22.

3.  New guidelines for HER2 pathological diagnostics in gastric cancer.
        Wada R, Hirabayashi K, Ohike N, Morii E.
          Pathol Int.  2016 Feb;66(2):57-62. 

2.  Necrotizing soft tissue infection caused by Serratia marcescens: A case report and
     literature review.
        Hagiya H, Ojima M, Yoshida T, Matsui T, Morii E, Sato K, Tahara S, Yoshida H, Tomono K.
          J Infect Chemother.  2016 Jan 14. 

1.  Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived
      Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.
        Kawamura A, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ito E, Watabe T,
        Masuda S, Toda K, Hatazawa J, Morii E, Sawa Y.
          Sci Rep.  2016 Jan 14;6:19464.
   

2015 年


 20. Anti-Cancer Effects of Nonequilibrium Atmospheric Pressure Plasma on
       Cancer-Initiating Cells in Human Endometrioid Adenocarcinoma Cells.
         Ikeda J, Tsuruta Y, Nojima S, Sakakita H, Hori M, Ikehara Y.
           Plasma Process Polym.  2015 Dec, 1370–1376.

19.  The significance of G-CSF expression and myeloid-derived suppressor cells in the
        chemoresistance of uterine cervical cancer.
         Kawano M, Mabuchi S, Matsumoto Y, Sasano T, Takahashi R, Kuroda H, Kozasa K,
         Hashimoto K, Isobe A, Sawada K, Hamasaki T, Morii E, Kimura T.
           Sci Rep.  2015 Dec 15;5:18217.

18.  The significance of lymphatic space invasion and its association with vascular
       endothelial growth factor-C expression in ovarian cancer.

         Hisamatsu T, Mabuchi S, Sasano T, Kuroda H, Takahashi R, Matsumoto Y, Kawano M,
         Kozasa K, Takahashi K, Sawada K, Matsuo K, Tamada Y, Morii E, Kitadai Y, Kimura T.
           Clin Exp Metastasis. 2015 Dec;32(8):789-98.

 17.  N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage
       dysfunction and enhances colitic tumorigenesis.

         Shinzaki S, Ishii M, Fujii H, Iijima H, Wakamatsu K, Kawai S, Shiraishi E, Hiyama S,
         Inoue T, Hayashi Y, Kuwahara R, Takamatsu S, Kamada Y, Morii E, Tsujii M,
         Takehara T, Miyoshi E.
           J Gastroenterol. 2015 Sep 8. [Epub ahead of print]

 16.  A Case of Nasopharyngeal Cancer with Febrile Neutropenia Followed by Death
       during Adjuvant Chemotherapy.

         Nakahara S, Kitamura K, Honma K, Yamamoto Y, Takenaka Y, Yasui T, Hanamoto A,
         Morii E, Inohara H.
           Nihon Jibiinkoka Gakkai Kaiho. 2015 Jun;118(6):763-9.

 15.  Epithelioid Rhabdomyosarcoma; a case report with immunohistochemical and
        molecular study.

          Jokoji R, Ikeda J, Tsujimoto M, Morii E.
            Diagn Pathol. 2015 Jul 25;10:124.

 14.  A Case of Extragonadal Teratoma in the Pouch of Douglas and Literature Review.
        Kakuda M, Matsuzaki S, Kobayashi E, Yoshino K, Morii E, Kimura T.
          J Minim Invasive Gynecol. 2015 Jul 20. pii: S1553-4650(15)00530-0.
          doi: 10.1016/j.jmig.2015.07.008. [Epub ahead of print]

 13.  Atypical glomus tumor arising in the liver: a case report.
         Hirose K, Matsui T, Nagano H, Eguchi H, Marubashi S, Wada H, Morii E.
           Diagn Pathol. 2015 Jul 19;10:112.

 12.  Primary central chondrosarcoma of long bone, limb girdle and trunk: Analysis of
       174 cases by numerical scoring on histology.

         Konishi E, Nakashima Y, Mano M, Tomita Y, Nagasaki I, Kubo T, Araki N, Haga H,
         Toguchida J, Ueda T, Sakuma T, Imahori M, Morii E, Yoshikawa H, Tsukamoto Y,
         Futani H, Wakasa K, Hoshi M, Hamada S, Takeshita H, Inoue T, Aono M, Kawabata K,
         Murata H, Katsura K, Urata Y, Ueda H, Yanagisawa A.
            Pathol Int. 2015 Sep;65(9):468-75 

 11.  mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for
       Optimal Activation and Differentiation of CD8+ T Cells.

          Ito D, Nojima S, Nishide M, Okuno T, Takamatsu H, Kang S, Kimura T, Yoshida Y,
          Morimoto K, Maeda Y, Hosokawa T, Toyofuku T, Ohshima J, Kamimura D, Yamamoto M,
          Murakami M, Morii E, Rakugi H, Isaka Y, Kumanogoh A.
             J Immunol. 2015 Aug 1;195(3):934-43.

 10.  The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and
        interferon-γ in colitis.

          Sato A, Kayama H, Shojima K, Matsumoto S, Koyama H, Minami Y, Nojima S, Morii E,
          Honda H, Takeda K, Kikuchi A.
            Sci Rep. 2015 Jun 1;5:10536.

  9.  Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu
       antibody-positive paraneoplastic peripheral neuropathy.

         Matsui T, Hori Y, Nagano H, Eguchi H, Marubashi S, Wada H, Wada N, Ikeda J,
         Sakamoto M, Morii E.
            Pathol Int. 2015 Jul;65(7):388-92

  8.  mLST8 Promotes mTOR-Mediated Tumor Progression.
         Kakumoto K, Ikeda J, Okada M, Morii E, Oneyama C.
           PLoS One. 2015 Apr 23;10(4):e0119015.

  7.  Solitary fibrous tumor of the liver from development to resection.
         Makino Y, Miyazaki M, Shigekawa M, Ezaki H, Sakamori R, Yakushijin T, Ohkawa K, Kato M,
         Akasaka T, Shinzaki S, Nishida T, Miyake Y, Hama N, Nagano H, Honma K, Morii E,
         Wakasa K, Hikita H, Tatsumi T, Iijima H, Hiramatsu N, Tsujii M, Takehara T.
           Intern Med. 2015;54(7):765-70.

  6.  Chemoradiotherapy is effective for primary esophageal adenosquamous cell
        carcinoma but ineffective for the metastatic adenocarcinoma component.

          Nozaki Y, Nishida T, Hori Y, Shinzaki S, Kato M, Yakushijin T, Iijima H, Tsujii M, Morii E,
          Takehara T.
            Nihon Shokakibyo Gakkai Zasshi. 2015;112(2):278-86.

   5.  Estrogen-inducible sFRP5 inhibits early B-lymphopoiesis in vivo, but not during
        pregnancy.

           Yokota T, Oritani K, Sudo T, Ishibashi T, Doi Y, Habuchi Y, Ichii M, Fukushima K,
           Okuzaki D, Tomizuka K, Yamawaki K, Kakitani M, Shimono A, Morii E, Kincade PW,
           Kanakura Y.
             Eur J Immunol. 2015 May;45(5):1390-401.

   4.  Interleukin 6 receptor is an independent prognostic factor and a potential
        therapeutic target of ovarian cancer.

           Isobe A, Sawada K, Kinose Y, Ohyagi-Hara C, Nakatsuka E, Makino H, Ogura T, Mizuno T,
           Suzuki N, Morii E, Nakamura K, Sawada I, Toda A, Hashimoto K, Mabuchi S, Ohta T,
           Morishige K, Kurachi H, Kimura T.
              PLoS One. 2015 Feb 6;10(2):e0118080.

    3.  Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission
       tomography in predicting World Health Organization grade in pancreatic
       neuroendocrine tumors.

            Tomimaru Y, Eguchi H, Tatsumi M, Kim T, Hama N, Wada H, Kawamoto K, Kobayashi S,
            Morii E, Mori M, Doki Y, Nagano H.
               Surgery. 2015 Feb;157(2):269-76. 

   2.  IKKβ regulates VEGF expression and is a potential therapeutic target for ovarian
       cancer as an anti-angiogenic treatment.

            Kinose Y, Sawada K, Makino H, Ogura T, Mizuno T, Suzuki N, Fujikawa T, Morii E,
            Nakamura K, Sawada I, Toda A, Hashimoto K, Isobe A, Mabuchi S, Ohta T, Itai A,
            Morishige KI, Kurachi H, Kimura T.
                Mol Cancer Ther. 2015 Jan 30.

   1.   Favine/CCDC3 is Involved in Lipid Accumulation.
              Kobayashi S, Fukuhara A, Otsuki M, Suganami T, Ogawa Y, Morii E, Shimomura I.
                  J Biol Chem. 2015 Jan 20.
   

2014 年


  24.  Rab11a is required for apical protein localisation in the intestine.
            Sobajima T, Yoshimura S, Iwano T, Kunii M, Watanabe M, Atik N, Mushiake S, Morii E,
            Koyama Y, Miyoshi E, Harada A.
                Biol Open. 2014 Dec 19;4(1):86-94

  23.  Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA
       damage repair.

            Oji Y, Tatsumi N, Kobayashi J, Fukuda M, Ueda T, Nakano E, Saito C, Shibata S,
            Sumikawa M, Fukushima H, Saito A, Hojo N, Suzuki M, Hoshikawa T, Shimura T,
            Morii E, Oka Y, Hosen N, Komatsu K, Sugiyama H.
                Mol Carcinog. 2014 Nov 21. 

  22.  A giant periosteal chondroma of the distal femur successfully reconstructed with
       synthetic bone grafts and a bioresorbable plate: a case report.

            Imura Y, Shigi A, Outani H, Hamada K, Tamura H, Morii E, Myoui A, Yoshikawa H, Naka N.
                World J Surg Oncol. 2014 Nov 22;12:354.

  21.  Clear cell adenocarcinoma of the peritoneum: a case report and literature
       review.

            Shigeta N, Yoshino K, Matsuzaki S, Morii E, Ueda Y, Kimura T.
                J Ovarian Res. 2014 Oct 2;7:86.

   20.  Placenta percreta with a vaginal fistula after successful management by uterine
       transverse fundal incision and subsequent cesarean hysterectomy.

             Matsuzaki S, Matsuzaki S, Ueda Y, Egawa-Takata T, Mimura K, Kanagawa T, Morii E,
             Kimura T.
                Obstet Gynecol Sci. 2014 Sep;57(5):397-400.

  19.  Esophageal early basaloid squamous carcinoma with unusual narrowband
       imaging magnified endoscopy findings.

             Kai Y, Kato M, Hayashi Y, Akasaka T, Shinzaki S, Nishida T, Tsujii M, Morii E, Takehara T.
                 World J Gastroenterol. 2014 Sep 21;20(35):12673-7.

  18.  In vivo evaluation of irinotecan-loaded QuadraSphere microspheres for use in
       chemoembolization of VX2 liver tumors.

            Tanaka K, Maeda N, Osuga K, Higashi Y, Hayashi A, Hori Y, Kishimoto K, Morii E, Ohashi F,
            Tomiyama N.
                J Vasc Interv Radiol. 2014 Nov;25(11):1727-35.e1.

  17.  [Correlation of PBX2/ELF2 expression with prognosis of non-small cell lung
       cancer].

             Jin SQ, Pu YF, Qiu Y, Aozasa K, Morii E.
                 Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jul;43(4):413-9. Chinese.

  16.  Embolic effects of transcatheter mesenteric arterial embolization with
       microspheres on the small bowel in a dog model.

             Kishimoto K, Osuga K, Maeda N, Higashi Y, Hayashi A, Hori Y, Nakamura M, Ohashi F,
             Morii E, Tomiyama N.
                  J Vasc Interv Radiol. 2014 Nov;25(11):1767-73.

  15.  Roles of histamine on the expression of aldehyde dehydrogenase 1 in
        endometrioid adenocarcinoma cell line.

             Wang Y, Jiang Y, Ikeda J, Tian T, Sato A, Ohtsu H, Morii E.
                 Cancer Med. 2014 Oct;3(5):1126-35.

  14.  Esophageal adenocarcinoma with white opaque substance observed by
        magnifying endoscopy with narrow band imaging.

             Yoshii S, Kato M, Honma K, Fujinaga T, Tsujii Y, Maekawa A, Inoue T, Hayashi Y,
             Akasaka T, Shinzaki S, Nishida T, Iijima H, Tsujii M, Morii E, Takehara T.
                Dig Endosc. 2014 Jul 16.

  13.  Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical
       entity with radioresistant feature.

            Mabuchi S, Matsumoto Y, Kawano M, Minami K, Seo Y, Sasano T, Takahashi R, Kuroda H,
            Hisamatsu T, Kakigano A, Hayashi M, Sawada K, Hamasaki T, Morii E, Kurachi H,
            Matsuura N, Kimura T.
               J Natl Cancer Inst. 2014 Jun 19;106(7).

  12.  Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma
        based 
on lepidic pattern in patients with pathological stage IA pulmonary
        adenocarcinoma.

              Nakagiri T, Sawabata N, Morii E, Inoue M, Shintani Y, Funaki S, Okumura M.
                 Gen Thorac Cardiovasc Surg. 2014 Nov;62(11):671-7.

    11.  Intrahepatic cholangiocarcinoma in a worker at an offset color proof-printing
       company: an autopsy case report.

            Tomimaru Y, Kobayashi S, Wada H, Hama N, Kawamoto K, Eguchi H, Kira T, Morii E,
            Doki Y, Mori M, Nagano H.
                Hepatol Res. 2014 May 22. doi: 10.1111/hepr.12363. [Epub ahead of print]

   10.  Human papillomavirus and cystic node metastasis in oropharyngeal cancer and
        cancer of unknown primary origin.

              Yasui T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T, Inohara H.
                 PLoS One. 2014 Apr 21;9(4):e95364. doi: 10.1371/journal.pone.0095364.

    9.  Endometrial adenocarcinoma arising in a Turner's syndrome patient with
       spontaneous menstruation: a case report.

            Sasamoto N, Ueda Y, Amemiya K, Enomoto T, Morii E, Adachi K.
                 J Reprod Med. 2014 Mar-Apr;59(3-4):177-80.

    8.  Prognostic Importance of Volumetric Measurements in Stage I Lung
       Adenocarcinoma.

           Yanagawa M, Tanaka Y, Leung AN, Morii E, Kusumoto M, Watanabe S, Watanabe H,
           Inoue M, Okumura M, Gyobu T, Ueda K, Honda O, Sumikawa H, Johkoh T, Tomiyama N.
              Radiology. 2014 Apr 6:131903.

    7.  Topical Treatment for Orbital Capillary Hemangioma in an Adult Using a
       β-Blocker Solution.

           Ohnishi K, Tagami M, Morii E, Azumi A.
               Case Rep Ophthalmol. 2014 Feb 20;5(1):60-5.

    6.  Assessment of Combination of Contrast-Enhanced Magnetic Resonance Imaging
       and Positron Emission Tomography/Computed Tomography for Evaluation of
       Ovarian Masses.

            Tsuboyama T, Tatsumi M, Onishi H, Nakamoto A, Kim T, Hori M, Sakane M, Hori Y,
            Morii E, Hatazawa J, Tomiyama N.
                Invest Radiol. 2014 Mar 14.

    5.  The translation elongation factor eEF2 is a novel tumor‑associated antigen
        overexpressed in various types of cancers.

             Oji Y, Tatsumi N, Fukuda M, Nakatsuka S, Aoyagi S, Hirata E, Nanchi I, Fujiki F,
             Nakajima H, Yamamoto Y, Shibata S, Nakamura M, Hasegawa K, Takagi S, Fukuda I,
             Hoshikawa T, Murakami Y, Mori M, Inoue M, Naka T, Tomonaga T, Shimizu Y,
             Nakagawa M, Hasegawa J, Nezu R, Inohara H, Izumoto S, Nonomura N, Yoshimine T,
             Okumura M, Morii E, Maeda H, Nishida S, Hosen N, Tsuboi A, Oka Y, Sugiyama H.
                  Int J Oncol. 2014 May;44(5):1461-9.

     4.  Human papillomavirus and p53 mutations in head and neck squamous cell
        carcinoma among Japanese population.

             Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y,                  Nakahara S, Todo T, Hongyo T, Inohara H.
                Cancer Sci. 2014 Apr;105(4):409-17.

    3.  Atypical duodenal ulcer and invagination caused by a large pedunculated
       duodenal Brunner's gland hamartoma.

           Nakabori T, Shinzaki S, Yamada T, Nishida T, Iijima H, Tsujii M, Kurokawa Y, Mori M,
           Doki Y, Morii E, Takehara T.
              Gastrointest Endosc. 2014 Apr;79(4):679-80: discussion 680.

   2.  Determinants of Response to Neoadjuvant Chemotherapy for Esophageal
       Cancer Using 18F-fluorodeoxiglucose Positron Emission Tomography
        (18F-FDG-PET).

            Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K,
            Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y.
               Ann Surg Oncol. 2014 Feb;21(2):575-82.

   1.  Characterization of subpopulation lacking both B-cell and plasma cell markers
        in Waldenstrom macroglobulinemia cell line.

            Wada N, Zhan M, Hori Y, Honma K, Ikeda JI, Morii E.
              Lab Invest. 2014 Jan;94(1):79-88.
     
     

2013 年

     
   14. MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.
           Oneyama C, Kito Y, Asai R, Ikeda J, Yoshida T, Okuzaki D, Kokuda R, Kakumoto K,
           Takayama K, Inoue S, Morii E, Okada M.
              PLoS One. 2013 Nov 11;8(11):e80300. doi: 10.1371/journal.pone.0080300.

   13. Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in
        endometrioid adenocarcinoma of uterus.

           Wang Y, Jiang Y, Tian T, Hori Y, Wada N, Ikeda JI, Morii E.
             Biochem Biophys Res Commun. 2013 Nov 1;440(4):731-6.

   12. Multimodality therapy for large cell neuroendocrine carcinoma of the thymus.
          Ose N, Inoue M, Morii E, Shintani Y, Sawabata N, Okumura M.
            Ann Thorac Surg. 2013 Oct;96(4):e85-7. 

   11. Expression of FoxO3a in clinical cases of malignant lymphoma.
           Ikeda JI, Tian T, Wang Y, Hori Y, Honma K, Wada N, Morii E.
             Pathol Res Pract. 2013 Nov;209(11):716-20.

   10. A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors
        with large cysts containing hemorrhagic fluid in vivo.

            Imura Y, Naka N, Outani H, Yasui H, Takenaka S, Hamada K, Ozaki R, Kaya M, Yoshida K,
            Morii E, Myoui A, Yoshikawa H.
             BMC Res Notes. 2013 Aug 1;6(1):305.

     9. Synchronous bilateral tonsillar carcinomas associated with human
        papillomavirus.

            Nakahara S, Yasui T, Takenaka Y, Yamamoto Y, Yoshii T, Morii E, Inohara H.
              Auris Nasus Larynx. 2013 Jul 17.

     8. Pulmonary fibroblasts induce epithelial mesenchymal transition and some
       characteristics of stem cells in non-small cell lung cancer.

           Shintani Y, Abulaiti A, Kimura T, Funaki S, Nakagiri T, Inoue M, Sawabata N, Minami M,
           Morii E, Okumura M.
             Ann Thorac Surg. 2013 Aug;96(2):425-33.

     7. Calretinin mediates apoptosis in small cell lung cancer cells expressing
        tetraspanin CD9.

            He P, Kuhara H, Tachibana I, Jin Y, Takeda Y, Tetsumoto S, Minami T, Kohmo S,
            Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Naka T, Morii E,
            Kawase I, Kumanogoh A.
              FEBS Open Bio. 2013 May 10;3:225-30.

     6. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages.
            Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, Yoshioka Y, Morii E,
            Takakura N, Takeuchi O, Akira S.
              Nature. 2013 Mar 28;495(7442):524-8.

     5. IL-6 amplifier activation in epithelial regions of bronchi after allogeneic lung
        transplantation.

            Lee J, Nakagiri T, Kamimura D, Harada M, Oto T, Susaki Y, Shintani Y, Inoue M, Miyoshi S,
            Morii E, Hirano T, Murakami M, Okumura M.
              Int Immunol. 2013 May;25(5):319-32.

     4. Conization using the Shimodaira-Taniguchi procedure for adenocarcinoma in
        situ of the uterine cervix.

           Hiramatsu K, Ueda Y, Yoshino K, Fujita M, Morii E, Enomoto T, Kimura T.
            Eur J Obstet Gynecol Reprod Biol. 2013 Feb 7.  [Epub ahead of print]

     3. Advanced gastric cancer deriving from submucosal heterotopic gastric glands
       based on pathological diagnosis.

           Nakamatsu D, Nishida T, Inoue T, Shigekawa M, Shinzaki S, Yamada T, Yakushijin T,
           Miyazaki M, Ezaki H, Kakita N, Tatsumi T, Iijima H, Kiso S, Hiramatsu N, Tsujii M, Doki Y,
           Mori M, Morii E, Takehara T.
             Nihon Shokakibyo Gakkai Zasshi. 2013;110(2):290-3.

     2. A point mutation in Semaphorin 4A associates with defective endosomal sorting
       and causes retinal degeneration.

           Nojima S, Toyofuku T, Kamao H, Ishigami C, Kaneko J, Okuno T, Takamatsu H, Ito D,
           Kang S, Kimura T, Yoshida Y, Morimoto K, Maeda Y, Ogata A, Ikawa M, Morii E, Aozasa K,
           Takagi J, Takahashi M, Kumanogoh A.
             Nat Commun. 2013 Jan 29;4:1406. doi: 10.1038/ncomms2420.

     1. Echinoderm Microtubule-Associated Protein-Like 4 (EML4)-Anaplastic
       Lymphoma Kinase (ALK) Rearrangement in Congenital Pulmonary Airway
       Malformation.

          Tetsumoto S, Kijima T, Morii E, Goya S, Minami T, Hirata H, Takahashi R, Kohmo S, Inoue K,
          Nagatomo I, Takeda Y, Kida H, Tachibana I, Kumanogoh A.
           Clin Lung Cancer. 2013 Jan 25.  [Epub ahead of print]
           
         
           

2012 年

 
    20. Toxic epidermal necrolysis complicated by sepsis, haemophagocytic syndrome,         and severe liver dysfunction associated with elevated interleukin-10  
        production.

           Yamaoka T, Azukizawa H, Tanemura A, Murota H, Hirose T, Hayakawa K, Shimazu T,
           Wada N, Morii E, Katayama I.
            Eur J Dermatol. 2012 Nov-Dec;22(6):815-7.

    19.  An accurate and rapid detection of lymph node metastasis in non-small cell
           lung cancer patients based on one-step nucleic acid amplification assay.

              Inoue M, Hiyama K, Nakabayashi K, Morii E, Minami M, Sawabata N, Shintani Y, Nakagiri T,
              Susaki Y, Maeda J, Higashiyama M, Okami J, Yoshida Y, Ding J, Otomo Y, Okumura M.
               Lung Cancer. 2012 Dec;78(3):212-8.

    18.  Comparison of the Prognoses of FIGO Stage I to Stage II Adenosquamous
           Carcinoma and
Adenocarcinoma of the Uterine Cervix Treated With
           Radical Hysterectomy.

              Mabuchi S, Okazawa M, Kinose Y, Matsuo K, Fujiwara M, Suzuki O, Morii E, Kamiura S,                     Ogawa K, Kimura T.
               Int J Gynecol Cancer. 2012 Oct;22(8):1389-1397.

    17.  Inhibitory effect of PPARγ on NR0B1 in tumorigenesis of lung adenocarcinoma.
             Susaki Y, Inoue M, Minami M, Sawabata N, Shintani Y, Nakagiri T, Funaki S, Aozasa K,
             Okumura M, Morii E.
              Int J Oncol. 2012 Jul 25. doi: 10.3892/ijo.2012.1571. [Epub ahead of print]

    16.  IL-6 Amplifier, NF-κB-Triggered Positive Feedback for IL-6 Signaling,
           in Grafts Is Involved
in Allogeneic Rejection Responses.
               Lee J, Nakagiri T, Oto T, Harada M, Morii E, Shintani Y, Inoue M, Iwakura Y, Miyoshi S,
               Okumura M, Hirano T, Murakami M.
                J Immunol. 2012 Aug 15;189(4):1928-36.
   
    15.  Prognostic significance of elongator protein 3 expression in endometrioid
           adenocarcinoma.

               Wang Y, Ikeda JI, Rahadiani N, Mamat S, Ueda Y, Tian T, Enomoto T, Kimura T,
               Aozasa K, Morii E.
               Oncol Lett. 2012 Jan;3(1):25-29.

    14.  Enormous Cystic Tumor of Peritoneal Psammocarcinoma Exhibiting Complete
           Response to Cisplatin and Cyclophosphamide after Suboptimal Cytoreduction:
           Case Report and Review of the Literature.

               Takahashi R, Ueda Y, Shioji M, Adachi S, Ohashi H, Morii E, Aozasa K, Yoshino K,
                Fujita M, Enomoto T, Kimura T, Tokuhira A.
                Gynecol Obstet Invest. 2012 May 11. [Epub ahead of print]
    
     13.  Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice.
           
    Uebi T, Itoh Y, Hatano O, Kumagai A, Sanosaka M, Sasaki T, Sasagawa S,
                Doi J, Tatsumi K, Mitamura K, Morii E, Aozasa K, Kawamura T, Okumura M,
                Nakae J, Takikawa H, Fukusato T, Koura M, Nish M, Hamsten A, Silveira A,
                Bertorello AM, Kitagawa K, Nagaoka Y, Kawahara H, Tomonaga T, Naka T,
                Ikegawa S, Tsumaki N, Matsuda J, Takemori H.
         
     PLoS One. 2012;7(5):e37803. Epub 2012 May 25.
     
     12.  Evaluation of Response to Neoadjuvant Chemotherapy for Esophageal Cancer:
             PET Response Criteria in Solid Tumors Versus Response Evaluation Criteria
             in Solid Tumors.

                 Yanagawa M, Tatsumi M, Miyata H, Morii E, Tomiyama N, Watabe T, Isohashi K,
                 Kato H, Shimosegawa E, Yamasaki M, Mori M, Doki Y, Hatazawa J.
                  J Nucl Med. 2012 Jun;53(6):872-80.

     11.  Bak deficiency inhibits liver carcinogenesis: A causal link between apoptosis
            and carcinogenesis.

               Hikita H, Kodama T, Shimizu S, Li W, Shigekawa M, Tanaka S, Hosui A, Miyagi T,
               Tatsumi T, Kanto T, Hiramatsu N, Morii E, Hayashi N, Takehara T.
                J Hepatol. 2012 Jul;57(1):92-100.

   10.  Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin
            lymphoma cells.

               Ikeda J, Mamat S, Tian T, Wang Y, Luo W, Rahadiani N, Aozasa K, Morii E.
               Lab Invest. 2012 Apr;92(4):606-14.


   9.  Altered Oligosaccharide Structures Reduce Colitis Induction in Mice Defective
          in 
β-1,4-Galactosyltransferase.
      Shinzaki S, Iijima H, Fujii H, Kuroki E, Tatsunaka N, Inoue T, Nakajima S, Egawa S,
      Kanto T, Tsujii M, Morii E, Takeishi S, Asano M, Takehara T, Hayashi N, Miyoshi E.
      Gastroenterology. 2012 May;142(5):1172-82.

     8. Role of leucine-rich pentatricopeptide repeat motif-containing protein
           (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.

        Tian T, Ikeda JI, Wang Y, Mamat S, Luo W, Aozasa K, Morii E.
        Eur J Cancer. 2012 Feb 10. [Epub ahead of print]

     7.  Diffuse large B cell lymphoma with an interfollicular pattern of proliferation
           shows a favourable prognosis: a study of the Osaka Lymphoma Study Group.

              Wada N, Zaki MA, Kohara M, Ogawa H, Sugiyama H, Nomura S, Matsumura I, Hino M,
              Kanakura Y, Inagaki H, Morii E, Aozasa K.
              Histopathology. 2012 May;60(6):924-932.

      6.  Inflammatory pseudotumor of the liver and spleen diagnosed by percutaneous
            needle biopsy.

               Kawaguchi T, Mochizuki K, Kizu T, Miyazaki M, Yakushijin T, Tsutsui S, Morii E,
               Takehara T.
               World J Gastroenterol. 2012 Jan 7;18(1):90-5.

      5.  Tumour-associated macrophages in diffuse large B-cell lymphoma: a study
              of the Osaka Lymphoma Study Group.

                  Wada N, Zaki MA, Hori Y, Hashimoto K, Tsukaguchi M, Tatsumi Y, Ishikawa J,
                  Tominaga N, Sakoda H, Take H, Tsudo M, Kuwayama M, Morii E, Aozasa K;
                  Osaka Lymphoma Study Group.
                  Histopathology. 2012 Jan;60(2):313-9.

      4.  In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres
              for use in chemoembolization of VX2 liver tumors.

                  Maeda N, Osuga K, Shimazu K, Morii E, Mikami K, Hori S, Nakazawa T, Higashihara H,
                  Tomoda K, Nakamura H, Tomiyama N.
                  J Vasc Interv Radiol. 2012 Mar;23(3):397-404.e1.

      3.   Slower growth of skull base meningiomas compared with non-skull base
               meningiomas based on volumetric and biological studies.

                   Hashimoto N, Rabo CS, Okita Y, Kinoshita M, Kagawa N, Fujimoto Y, Morii E,
                   Kishima H, Maruno M, Kato A, Yoshimine T.
                    J Neurosurg. 2012 Mar;116(3):574-80.

      2.  Mapping analysis of ghrelin producing cells in the human stomach associated
              with chronic 
gastritis and early cancers.
                 Takiguchi S, Adachi S, Yamamoto K, Morii E, Miyata H, Nakajima K, Yamasaki M,
                 Kangawa K, Mori M, Doki Y.
                 Dig Dis Sci. 2012 May;57(5):1238-46.

      1.   Prediction, based on resection margins, of long-term outcome of cervical
               intraepithelial 
neoplasia 3 treated by Shimodaira-Taniguchi conization.
               Miyoshi Y, Miyatake T, Ueda Y, Morimoto A, Yokoyama T, Matsuzaki S, Kimura T,
               Yoshino K, Fujita M, Ohashi H, Morii E, Enomoto T, Kimura T.
               Arch Gynecol Obstet. 2012 May;285(5):1427-32.

   

2011 年 以前 (抜粋)

                    
     ● Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by
          Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of
          Endometrial Adenocarcinoma.

               Mamat S, Ikeda J, Tian T, Wang Y, Luo W, Aozasa K, Morii E.
               Genes Cancer. 2011 Oct;2(10):979-84.
   
     ● Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid          
           adenocarcinoma and its 
clinical implications.
               Rahadiani N, Ikeda J, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Wang Y,
               Enomoto T, Kimura T, Aozasa K, Morii E.
               Cancer Sci. 2011 Apr;102(4):903-8.
    
    ●  Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma
            cell lines.

                Ikeda J, Mamat S, Tian T, Wang Y, Rahadiani N, Aozasa K, Morii E.
                Am J Pathol. 2010 Dec;177(6):3081-8.

      ●  Prognostic significance of CUB domain containing protein expression in
            endometrioid adenocarcinoma.

                Mamat S, Ikeda J, Enomoto T, Ueda Y, Rahadiani N, Tian T, Wang Y, Qiu Y, Kimura T,
                Aozasa K, Morii E.
                Oncol Rep. 2010 May;23(5):1221-7.